Diabetes in China: a societal solution for a personal challenge (Q41740417)

8 October 2017

Diabetes in China: a societal solution for a personal challenge (English)

1 reference

People's Republic of China

8 October 2017

0 references

author

Juliana Chung-ngor Chan

series ordinal

1

1 reference

8 October 2017

Yuying Zhang

2

1 reference

PubMed ID

25218728

8 October 2017

Guang Ning

series ordinal

3

1 reference

8 October 2017

10 September 2014

1 reference

The Lancet: Diabetes & Endocrinology

8 October 2017

1 reference

8 October 2017

2

1 reference

8 October 2017

969-979

1 reference

8 October 2017

12

1 reference

Human evolution. Diabetes running wild

8 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Exposure to the Chinese famine in early life and the risk of hyperglycemia and type 2 diabetes in adulthood

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Prevalence and control of diabetes in Chinese adults

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Diabetes and noncommunicable disease: prevent the preventables

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Effects of telephone-based peer support in patients with type 2 diabetes mellitus receiving integrated care: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Stress Hormones: Their Interaction and Regulation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Metabolic implications of body fat distribution

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Effect of in utero and early-life conditions on adult health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Birth weight and non-insulin dependent diabetes: thrifty genotype, thrifty phenotype, or surviving small baby genotype?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Prevalence of diabetes among men and women in China

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Globalization of diabetes: the role of diet, lifestyle, and genes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Sugar-sweetened beverages and genetic risk of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Why have physical activity levels declined among Chinese adults? Findings from the 1991-2006 China Health and Nutrition Surveys

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

The road to obesity or the path to prevention: motorized transportation and obesity in China

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Environmental Pollution in China: Status and Trends

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Relationship of urinary bisphenol A concentration to risk for prevalent type 2 diabetes in Chinese adults: a cross-sectional analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Environmental and socio-economic factors as contributors to racial disparities in diabetes prevalence.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Non-insulin-dependent diabetes mellitus in minorities in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Co-occurrence of diabetes and depression: conceptual considerations for an emerging global health challenge

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Diabetes and its chronic complications in the She ethnic minority group of China

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

The prevalence of hypertension, obesity and dyslipidemia in individuals of over 30 years of age belonging to minorities from the pasture area of Xinjiang

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Prevalence of major cardiovascular risk factors and adverse risk profiles among three ethnic groups in the Xinjiang Uygur Autonomous Region, China

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

educational level, obesity and incidence of diabetes among Chinese adult men and women aged 18-59 years old: an 11-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Association between sleeping hours, working hours and obesity in Hong Kong Chinese: the 'better health for better Hong Kong' health promotion campaign.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Low levels of awareness of suboptimal health conditions in a high-risk working population: the "better health for better Hong Kong" health promotion campaign

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Diabetes and its comorbidities--where East meets West

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

The role of adipocytokines and neurohormonal dysregulation in metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Diabetes in Asia: epidemiology, risk factors, and pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Insulin clamp-derived measurements of insulin sensitivity and insulin secretion in lean and obese asian type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Vascular disease prevalence in diabetic patients in China: standardised comparison with the 14 centres in the WHO Multinational Study of Vascular Disease in Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Diabetic nephropathy--what are the unmet needs?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Risk factors in V-shaped risk associations with all-cause mortality in type 2 diabetes-The Hong Kong Diabetes Registry

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

The Complexity of Vascular and Non-Vascular Complications of Diabetes: The Hong Kong Diabetes Registry.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Challenges to effective cancer control in China, India, and Russia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Cohort profile: risk evaluation of cancers in Chinese diabetic individuals: a longitudinal (REACTION) study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Diabetes and cancer: the mechanistic implications of epidemiological analyses from the Hong Kong Diabetes Registry.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Endocrine disruptors in the etiology of type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Depression and type 2 diabetes: cortisol pathway implication and investigational needs

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Active Smoking and the Risk of Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Chen Zhu: from barefoot doctor to China's Minister of Health

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

1 reference

7 January 2021

Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

High incidence of diabetic nephropathy in early-onset Japanese NIDDM patients. Risk analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Premature Mortality and Comorbidities in Young-onset Diabetes: A 7-Year Prospective Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Prospective Study on the Incidences of Cardiovascular-Renal Complications in Chinese Patients With Young-Onset Type 1 and Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Characteristics of insured patients with persistent gaps in diabetes care services: the Translating Research into Action for Diabetes (TRIAD) study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Genomics, type 2 diabetes, and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Nonlaboratory-based risk assessment algorithm for undiagnosed type 2 diabetes developed on a nation-wide diabetes survey

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Gestational diabetes, maternal obesity, and the NCD burden

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Early identification of type 2 diabetes: policy should be aligned with health systems strengthening

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

A community-based diabetes prevention and management education program in a rural village in India

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Effect of a multifactorial intervention on mortality in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Review of the effects of the traditional Chinese medicine Rehmannia Six Formula on diabetes mellitus and its complications

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Sustained antidiabetic effects of a berberine-containing Chinese herbal medicine through regulation of hepatic gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

A systematic review on use of Chinese medicine and acupuncture for treatment of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Medical care and payment for diabetes in China: enormous threat and great opportunity.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Ecological approaches to self-management: the case of diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Multidrug treatment of type 2 diabetes: a challenge for compliance

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Diabetes patient education: a meta-analysis and meta-regression

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

The value of self-monitoring of blood glucose: a review of recent evidence

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Consultation length in general practice: cross sectional study in six European countries

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Efficacy of structured education in patients with type 2 diabetes mellitus receiving insulin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Epidemiology and prevention of stroke: a worldwide perspective

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Effects of self-care, self-efficacy, social support on glycemic control in adults with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Peer support for self-management of diabetes improved outcomes in international settings

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Multifaceted determinants for achieving glycemic control: the International Diabetes Management Practice Study (IDMPS)

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Aspirin increases mortality in diabetic patients without cardiovascular disease: a Swedish record linkage study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Changing office practice and health care systems to facilitate diabetes self-management

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Attending the diabetes center is associated with increased 5-year survival probability of diabetic patients: the Verona Diabetes Study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Monitoring the Targets of the St Vincent Declaration and the Implementation of Quality Management in Diabetes Care: the DiabCare Initiative

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Launch of the health-care reform plan in China

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Application of economic analysis to diabetes and diabetes care

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

Development of retinopathy and proteinuria in relation to plasma-glucose concentrations in Pima Indians.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970144-5

7 January 2021

10.1016/S2213-8587(14)70144-5

Identifiers

DOI

1 reference

8 October 2017

1 reference

PubMed ID

25218728